APA (7th ed.) Citation

XW, L., YF, C., L, Z., P, Z., P, H., Q, N., & JC, L. (2025). Scutellarin mitigates LPS-ATP-induced cardiomyocyte pyroptosis through the inhibition of the NLRP3/caspase-1/GSDMD signalling pathway. Acta pharmaceutica (Zagreb, Croatia), 75(3), 517. https://doi.org/10.2478/acph-2025-0025

Chicago Style (17th ed.) Citation

XW, Li, Chen YF, Zhou L, Zhou P, Huang P, Niu Q, and Li JC. "Scutellarin Mitigates LPS-ATP-induced Cardiomyocyte Pyroptosis Through the Inhibition of the NLRP3/caspase-1/GSDMD Signalling Pathway." Acta Pharmaceutica (Zagreb, Croatia) 75, no. 3 (2025): 517. https://doi.org/10.2478/acph-2025-0025.

MLA (9th ed.) Citation

XW, Li, et al. "Scutellarin Mitigates LPS-ATP-induced Cardiomyocyte Pyroptosis Through the Inhibition of the NLRP3/caspase-1/GSDMD Signalling Pathway." Acta Pharmaceutica (Zagreb, Croatia), vol. 75, no. 3, 2025, p. 517, https://doi.org/10.2478/acph-2025-0025.